People with the rare growth hormone disorder acromegaly have a significantly higher risk of developing various types of ...

Arcus Biosciences’ quemliclustat receives US FDA orphan drug designation to treat pancreatic cancer: Hayward, California Tuesday, July 15, 2025, 13:00 Hrs [IST] Arcus Bioscience ...

Quest Diagnostics Incorporated (NYSE:DGX) is one of the 7 most undervalued pot stocks to buy according to analysts.

When researchers used a gene therapy to restore blood vessel health by counteracting the effects of Activin-A, they were able to prevent muscle loss.

A test developed by a Madison company to better track cancer DNA in the blood stream will now be covered by Medicare.

The test claims to analyse epigenomic and genomic data from circulating, cell-free DNA obtained from a simple blood draw.

Methylation changes in microbiome-derived cfRNA enable more accurate CRC diagnosis than traditional DNA or abundance-based ...

The San Diego-based firm said that it is transitioning beyond laboratory-developed tests and expanding access to its tests for the detection of early-stage cancers.

Could a sea cucumber sugar transform cancer care? A new study reveals its enzyme-blocking potential and safer profile ...

Lack of early detection: One risk factor is also the fact that there are no early detection methods for pancreatic cancer, unlike breast or colon cancer. Future research will focus on blood tests ...